The Japanese-American Bio-pharmaceutical Industry Research Paper by CalDR

This paper discusses how the Japanese-American bio-pharmaceutical industry represents an ongoing international effort between the two top pharmaceutical markets in the world. It looks at why a number of pharmaceutical products that are currently available to U.S. residents are unavailable to Japanese consumers and how from a humanitarian perspective, this discrepancy denies access to life-enhancing and life-saving drugs to the Japanese population. It proposes a study to evaluate how the United States and Japan can work collaboratively to optimize the availability of ethical pharmaceuticals so that every American and Japanese citizen is permitted free access to life-enhancing and life-saving drugs.

Outline
List of Tables
List of Figures
Chapters
1.Introduction
Statement of the Problem
Importance of the Problem
Definition of Terms
Limitations and Delimitations
2.Review of the Literature
1990 to 1996
1997 to 2002
3.Methodology
Research Design
The Hypothesis
Special Tests
Statistical Procedures Used
Data Gathering
Population Descriptions
4. Results
Statement of the Results
Tables
Charts
Figures
Statistical Findings
5.Summary
Conclusions
Supporting Findings
Contradicting Findings
Recommendations
Additional Research
Implications for Revising the Current Body of Knowledge
Change in Related Practices
Appendices